Chan-Tack KM - Search Results

1

The varying specificity of urine cultures in different populations.

Chan-Tack KM, Trautner BW, Morgan DJ. Chan-Tack KM, et al. Infect Control Hosp Epidemiol. 2020 Apr;41(4):489-491. doi: 10.1017/ice.2020.16. Epub 2020 Feb 10. Infect Control Hosp Epidemiol. 2020. PMID: 32036807 Review. No abstract available.

2

How Often Are Drugs Made Available Under the Food and Drug Administration's Expanded Access Process Approved?

McKee AE, Markon AO, Chan-Tack KM, Lurie P. McKee AE, et al. Among authors: chan tack km. J Clin Pharmacol. 2017 Oct;57 Suppl 10:S136-S142. doi: 10.1002/jcph.960. J Clin Pharmacol. 2017. PMID: 28921646 Review.

3

FDA Approval of Remdesivir - A Step in the Right Direction.

Rubin D, Chan-Tack K, Farley J, Sherwat A. Rubin D, et al. N Engl J Med. 2020 Dec 31;383(27):2598-2600. doi: 10.1056/NEJMp2032369. Epub 2020 Dec 2. N Engl J Med. 2020. PMID: 33264539 No abstract available.

4

Expanded access to investigational drugs.

Lurie P, Chan-Tack KM, Woodcock J. Lurie P, et al. Among authors: chan tack km. N Engl J Med. 2015 Apr 9;372(15):1473. doi: 10.1056/NEJMc1501823. N Engl J Med. 2015. PMID: 25853763 No abstract available.

5

Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.

Chan-Tack KM, Harrington PR, Choi SY, Myers L, O'Rear J, Seo S, McMillan D, Ghantous H, Birnkrant D, Sherwat AI. Chan-Tack KM, et al. Lancet Infect Dis. 2019 Jun;19(6):e221-e224. doi: 10.1016/S1473-3099(18)30788-6. Epub 2019 Mar 7. Lancet Infect Dis. 2019. PMID: 30853252 Review.

6

Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).

Chan-Tack KM, Kim C, Moruf A, Birnkrant DB. Chan-Tack KM, et al. Antivir Ther. 2015;20(5):561-4. doi: 10.3851/IMP2944. Epub 2015 Feb 10. Antivir Ther. 2015. PMID: 25667992 Review.

7

Why did the FDA approve efavirenz 800 mg when co-administered with rifampin?

Liu J, Chan-Tack KM, Jadhav P, Seo S, Robertson SM, Kraft J, Singer ME, Struble KA, Arya V. Liu J, et al. Among authors: chan tack km. Int J Clin Pharmacol Ther. 2014 Jun;52(6):446-53. doi: 10.5414/CP202079. Int J Clin Pharmacol Ther. 2014. PMID: 24755134

8

Clinical experience with intravenous zanamivir under an emergency investigational new drug program in the United States.

Chan-Tack KM, Gao A, Himaya AC, Thompson EG, Singer ME, Uyeki TM, Birnkrant DB. Chan-Tack KM, et al. J Infect Dis. 2013 Jan 1;207(1):196-8. doi: 10.1093/infdis/jis637. Epub 2012 Oct 22. J Infect Dis. 2013. PMID: 23089591 Free PMC article. No abstract available.

9

Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008).

Soon GG, Min M, Struble KA, Chan-Tack KM, Hammerstrom T, Qi K, Zhou S, Bhore R, Murray JS, Birnkrant DB. Soon GG, et al. Among authors: chan tack km. AIDS Patient Care STDS. 2012 Aug;26(8):444-53. doi: 10.1089/apc.2011.0278. Epub 2012 Jun 26. AIDS Patient Care STDS. 2012. PMID: 22734949

10

Use of ribavirin to treat influenza.

Chan-Tack KM, Murray JS, Birnkrant DB. Chan-Tack KM, et al. N Engl J Med. 2009 Oct 22;361(17):1713-4. doi: 10.1056/NEJMc0905290. N Engl J Med. 2009. PMID: 19846864 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page